Cached score snapshot

US.LH · Labcorp

110分制 59/110；5D動能v2 23/50；排序分 82/160

Back to ranking Open volume snapshot

Ranking score 82/160

Main score 59/110

5D momentum v2 23/50

Rank #29

Setup grade D 40.5

Score breakdown

觀望

Medium database-backfill

Score and price trend

D 40.5 Money flow A · Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

**Historical projection**
Model	Median	P25/P75	歷史相似情境上漲比例	Down5	Actual / compare
Rolling DOE best · score 2.678 · anchors 20	+0.39%	-1.36% / +2.46%	57.5%	5.8%	Actual -1.71% · vs median -2.10% · inside 25-75 band
Historical projection 10D n=160	+0.32%	-1.36% / +2.36%	53.8%	8.1%	Actual +0.33% · vs median +0.01% · inside 25-75 band

歷史情境統計基於已存檔相似 setup；圖中投影中位線為統計中位數的線性插值展示，並非價格路徑預測或買賣建議。

2026-01-02 → 2026-07-09 · 129 archived points · 1 Improving turn signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 82

Display grade 觀望

Model version cursor_18_27_news_v2_160

Main score 59/110 (觀望)

5D momentum v2 23/50 (中)

Score with momentum v2 82/160 (低排序)

Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 145

ma20 256.42

ma50 259.9272

close 271.31

prevClose 270.87

avgVolume20 763870

volumeRatio 1.57

changePercent 0.16

Metrics snapshot

close 271.31

volume 1198900

changePercent 0.16

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 59/110

Main rating 觀望

5D momentum v2 23/50

Score with momentum v2 82/160

Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 3.6/5 · 良好

Dimension score 3.6/5

Dimension grade 良好

Sub-items

pbPoints 0.5

pePoints 0.4

epsPoints 0.6

roePoints 0.4

debtPoints 0.4

marginPoints 0

turnoverUsdM 325.2736

volumePoints 0.5

revenuePoints 0

dividendPoints 0.3

marketCapPoints 0.5

資金流 — 15.6/20 · 良好

Dimension score 15.6/20

Dimension grade 良好

Sub-items

cmfPoints 3.2

mfiPoints 3.2

obvPoints 4

vwapPoints 3.2

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL

symbol US.LH

message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.

optional true

holderCount n/a

holderPoints 2

top10ShareRatio n/a

concentrationPenalty 0

institutionPoints 2

市場環境 — 9/15 · 一般

Dimension score 9/15

Dimension grade 一般

Sub-items

vix

score 1.8

details

source twelvedata+fred+database-backfill-market-proxy

vixClose 20.09

trend

score 3.4

details

qqq

ma20 121.9847

ma50 119.4142

name QQQ

close 120.0299

points 1.4

spy

ma20 112.5335

ma50 110.2373

name SPY

close 112.7733

points 2

source twelvedata+fred+database-backfill-market-proxy

atrPct 2.3357

atrPoints 3

cciPoints 0.8

vixPoints 1.8

marketTrendPoints 3.4

催化劑 — 2/20 · 較差

Dimension score 2/20

Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model

articleCount 6

catalystCount 0

catalystPoints 2

風險管理 — 7.4/10 · 良好

Dimension score 7.4/10

Dimension grade 良好

Sub-items

position

score 1.6

details

atrPct 2.3357

turnoverUsdM 325.2736

liquidityPoints 0.6

volatilityPoints 1

rrPoints 1.4

stopLevels

symbol US.LH

rr_range 1:1.0-1:2.5

risk_profile 中等

stop_loss_price 258.6358

strength_details

ma_score 1

atr_score 2

rsi_score 0.5

macd_score 3

volume_score 2

market_adjustment 1

risk_reward_ratio 1.1

stop_loss_percent 4.7

take_profit_price 285.3572

target_multiplier 1.9

technical_strength 1.75

take_profit_percent 5.2

positionPoints 1.6

stopLossPoints 2.4

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used

sector Health Care

concentratedSectorPenalty 0

riskRewardRatio 1.2

stopLossPercent 4.6715

diversificationPoints 2

技術信號 — 19.4/30 · 一般

Dimension score 19.4/30

Dimension grade 一般

Sub-items

bbPoints 3

adxPoints 3

sarPoints 2.4

vcpPoints 0.9

macdPoints 4

vcpPayload

vcp_pass false

vcp_score 0.9

vcp_reason 站上MA50；升放量(近10日4日)；Ready=N；Confirm=Y

vcp_metrics

up_days 6

vol_ref 694990

down_days 3

vcp_ready false

above_ma50 true

avg_vol_10 882510

avg_vol_20 757060

avg_vol_30 694990

range_pct_10 0.0981

range_pct_20 0.0981

range_pct_30 0.0981

up_expand_ok true

lookback_used 79

near_20d_high true

contraction_ok false

down_shrink_ok false

up_expand_days 4

breakout_20d_ok false

vol_ratio_10_30 1.2698

dist_to_20d_high 0.0011

down_shrink_days 2

breakout_level_20d 271.61

vcp_breakout_confirm true

contraction_ratio_10_30 1

vcp_name_en Volatility Contraction Pattern

vcp_name_zh 波動收縮形態

vol_contraction false

kdjAdxPoints 0.7

rsiKdjPoints 2.4

volumeWeight 2

maCrossPoints 0

shortRsiPoints 0.4

shortMacdPoints 0.4

volConfirmPoints 1

volumePointsTechnical 1.2

情緒分析 — 2/10 · 較差

Dimension score 2/10

Dimension grade 較差

Sub-items

sentiment

score 2

details

source finnhub_news_keyword_model

articleCount 6

negativeHits 0

positiveHits 0

sentimentScoreRaw 0

sentimentData

raw {"id":140639073,"url":"https://finnhub.io/api/news?id=de61a69e5ebc70655f7e5d02d4a50ab3177fa3118cf0d4825d9bba0012b8097f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"LH vs. CRL: Which Stock Is the Better Value Option?","category":"company","datetime":1781538002,"headline":"LH vs. CRL: Which Stock Is the Better Value Option?"}, {"id":140515389,"url":"https://finnhub.io/api/news?id=774538fd07490db4d638cadcc28a6d53b616073e8763adf671ba041005d7aa10","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"LH","summary":"Labcorp Holdings Inc. (LH) Jefferies Global Healthcare Conference 2026 June 3, 2026 12:15 PM EDTCompany ParticipantsJulia Wang - CFO & Executive...","category":"company","datetime":1780496542,"headline":"Labcorp Holdings Inc. (LH) Presents at Jefferies Global Healthcare Conference 2026 Transcript"}, {"id":140498514,"url":"https://finnhub.io/api/news?id=5e114c37ae4f826480cb1dd39e86fd2dc55d4daf9554d5b12c9e62ed4bf7f48a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp Holdings stock snapshot Labcorp Holdings (LH) stock has been moving without a clear single catalyst, which leads many investors to focus on its fundamentals, including recent returns, revenue, earnings and its current valuation profile. See our latest analysis for Labcorp Holdings. At a share price of $256.87, Labcorp Holdings has seen its short term share price momentum cool, with the share price down over the past week and three months, while longer term total shareholder returns...","category":"company","datetime":1780395006,"headline":"Assessing Labcorp (LH) Valuation As Shares Cool And P/E Trails Healthcare Peers"}, {"id":140488110,"url":"https://finnhub.io/api/news?id=992ea0469bef42f8b40689dfd5fdd6a55766857139763ab422f12ec43ea79f96","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp joins a national CRC trial as exclusive genetic testing provider, expanding Invitae-based testing and supporting cancer research.","category":"company","datetime":1780319460,"headline":"LH Expands Genetic Testing in CRC Through New Collab: Stock to Gain?"}, {"id":140434993,"url":"https://finnhub.io/api/news?id=d1e6611cf84320753cff656dc5eef71bf4c5d2bd577c2049db524448cdb630bd","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"LH vs. MEDP: Which Stock Is the Better Value Option?","category":"company","datetime":1779896402,"headline":"LH or MEDP: Which Is the Better Value Stock Right Now?"}, {"id":140404664,"url":"https://finnhub.io/api/news?id=77ed0ea7e926c76a7a0ebe0acddd9b686b25c54efaf669d91cd79f158b532059","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...","category":"company","datetime":1779624160,"headline":"Should Income Investors Look At Labcorp Holdings Inc. (NYSE:LH) Before Its Ex-Dividend?"}

raw_source {"id":140665236,"url":"https://finnhub.io/api/news?id=10a66dda14b20e65fc5be2ae6f7932dd68373d8b45a9c33eed65c7ea20cc6dbe","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp Holdings has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.","category":"company","datetime":1781789504,"headline":"Is Labcorp Holdings Stock Underperforming the Nasdaq?"}, {"id":140639073,"url":"https://finnhub.io/api/news?id=de61a69e5ebc70655f7e5d02d4a50ab3177fa3118cf0d4825d9bba0012b8097f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"LH vs. CRL: Which Stock Is the Better Value Option?","category":"company","datetime":1781538002,"headline":"LH vs. CRL: Which Stock Is the Better Value Option?"}, {"id":140618832,"url":"https://finnhub.io/api/news?id=272569004de73cf01b174436efcaf73184901a79faac62435280a914530782e9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.","category":"company","datetime":1781270103,"headline":"CVS Health Corporation (CVS) Hit a 52 Week High, Can the Run Continue?"}, {"id":140609077,"url":"https://finnhub.io/api/news?id=52cb62043ec768f9f9e24fc0e0a86cb23b7137eb792de52b160b3f0acbca4f07","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Danaher is seeing strong Biotechnology growth as bioprocessing demand rises, with equipment orders up more than 30% and core revenue gains expected in 2026.","category":"company","datetime":1781190900,"headline":"Strong Performance Continues at DHR's Biotechnology Unit: What's Next?"}, {"id":140592983,"url":"https://finnhub.io/api/news?id=4b4d210212f29130131f5753f26b586179aa36b63499bc98b011610995370363","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.","category":"company","datetime":1781099608,"headline":"2 S&P 500 Stocks for Long-Term Investors and 1 Facing Challenges"}, {"id":140571189,"url":"https://finnhub.io/api/news?id=9ada86ca899821337305d9c82d593c39853287fee467adf28995985167622996","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp OnDemand enables convenient testing with the NASHnext® test, within a physician-directed care pathway to support identification of patients with at-risk MASH This model expands access and supports adoption of NASHnext®, enabling testing across a wider patient population Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), June 8, 2026 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threateni","category":"company","datetime":1780934400,"headline":"GENFIT: NASHnext®, Powered by GENFIT's Non-invasive Diagnostic Technology NIS4®, Launched via Labcorp’s OnDemand Offering for Identification of At-Risk MASH"}, {"id":140535106,"url":"https://finnhub.io/api/news?id=c57369c47aa907aaf1780d15a262ad0b4f4f1dab02017c63aa94889e370381aa","image":"https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp","source":"ChartMill","related":"LH","summary":"Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.","category":"company","datetime":1780662900,"headline":"Top S&P500 movers in Friday's pre-market session"}, {"id":140525739,"url":"https://finnhub.io/api/news?id=c5513d86ae4d6e92580370a84278b71d8dbd2b6fa350581d6e3c27b2b5bec21a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1780587021,"headline":"Why Is Pediatrix Medical Group (MD) Down 1.7% Since Last Earnings Report?"}, {"id":140515389,"url":"https://finnhub.io/api/news?id=774538fd07490db4d638cadcc28a6d53b616073e8763adf671ba041005d7aa10","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"LH","summary":"Labcorp Holdings Inc. (LH) Jefferies Global Healthcare Conference 2026 June 3, 2026 12:15 PM EDTCompany ParticipantsJulia Wang - CFO & Executive...","category":"company","datetime":1780496542,"headline":"Labcorp Holdings Inc. (LH) Presents at Jefferies Global Healthcare Conference 2026 Transcript"}, {"id":140498514,"url":"https://finnhub.io/api/news?id=5e114c37ae4f826480cb1dd39e86fd2dc55d4daf9554d5b12c9e62ed4bf7f48a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp Holdings stock snapshot Labcorp Holdings (LH) stock has been moving without a clear single catalyst, which leads many investors to focus on its fundamentals, including recent returns, revenue, earnings and its current valuation profile. See our latest analysis for Labcorp Holdings. At a share price of $256.87, Labcorp Holdings has seen its short term share price momentum cool, with the share price down over the past week and three months, while longer term total shareholder returns...","category":"company","datetime":1780395006,"headline":"Assessing Labcorp (LH) Valuation As Shares Cool And P/E Trails Healthcare Peers"}, {"id":140488110,"url":"https://finnhub.io/api/news?id=992ea0469bef42f8b40689dfd5fdd6a55766857139763ab422f12ec43ea79f96","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp joins a national CRC trial as exclusive genetic testing provider, expanding Invitae-based testing and supporting cancer research.","category":"company","datetime":1780319460,"headline":"LH Expands Genetic Testing in CRC Through New Collab: Stock to Gain?"}, {"id":140458416,"url":"https://finnhub.io/api/news?id=ea3715563c18fce156cc272ed85db7157100b2cf49b370dc126207b518094d10","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.","category":"company","datetime":1780067558,"headline":"3 Cash-Producing Stocks That Concern Us"}, {"id":140456467,"url":"https://finnhub.io/api/news?id=31fb7e3919ea2811fb4a43a76978f99bd6ff3db924deb8372d17967db068cc1c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced a collaboration with the Alliance for Clinical Trials in Oncology to advance a national, multicenter clinical trial for patients newly diagnosed with colorectal cancer (CRC). The trial will evaluate approaches to increase germline genetic testing among at-risk family members, as well as the impact of multigene panel testing on care for newly diagnosed patients. Leveraging its Invitae testing,","category":"company","datetime":1780052400,"headline":"Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer"}, {"id":140464997,"url":"https://finnhub.io/api/news?id=1eb1dd8b7ae4ff7cd771703e1a7b4e1fd1583afcf7e686d0adce9046489559b7","image":"","source":"Benzinga","related":"LH","summary":"The trial will evaluate approaches to increase germline genetic testing among at-risk family members, as well as the impact of multigene panel testing on care for newly diagnosed patients. Leveraging its Invitae testing,","category":"company","datetime":1780038340,"headline":"Labcorp Enters Collaboration The Alliance For Clinical Trials In Oncology To Advance A National, Multicenter Clinical Trial For Patients Newly Diagnosed With Colorectal Cancer"}, {"id":140442845,"url":"https://finnhub.io/api/news?id=6102a259c1b9ea27cb85e6e3a53b61e2778334934272b0572fad7ec970c3755e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the availability of its expanded DPYD Genotyping test to help identify cancer patients who may be at increased risk for severe or life-threatening side effects from fluoropyrimidine chemotherapy. Labcorp now offers genotype testing for all DPYD Tier 1 and Tier 2 variants recommended by the Association for Molecular Pathology (AMP).","category":"company","datetime":1779966000,"headline":"Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side Effects"}, {"id":140451399,"url":"https://finnhub.io/api/news?id=49eec411d6f77958e2edbce8a614fc36185036e211809ab8a22185b60771a44f","image":"","source":"Benzinga","related":"LH","summary":"New pharmacogenomic test detects all DPYD variants recommended by the Association for Molecular Pathology to support safer, more personalized cancer treatmentBURLINGTON, N.C., May 28, 2026 /PRNewswire/ -- Labcorp","category":"company","datetime":1779952443,"headline":"Labcorp Announces Availability Of Expanded DPYD Genotyping Test To Help Identify Cancer Patients At Increased Risk For Severe Fluoropyrimidine Chemotherapy Side Effects"}, {"id":140434993,"url":"https://finnhub.io/api/news?id=d1e6611cf84320753cff656dc5eef71bf4c5d2bd577c2049db524448cdb630bd","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"LH vs. MEDP: Which Stock Is the Better Value Option?","category":"company","datetime":1779896402,"headline":"LH or MEDP: Which Is the Better Value Stock Right Now?"}, {"id":140432140,"url":"https://finnhub.io/api/news?id=b031e67f0c819876a02e9d062a5b32091e021a3b10907f4ff168655635a23816","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that the company will present at the 2026 Jefferies Global Healthcare Conference in New York on Wednesday, June 3, from 12:15 pm to 12:45 pm ET.","category":"company","datetime":1779883200,"headline":"Labcorp to Present at the Jefferies Global Healthcare Conference"}, {"id":140422829,"url":"https://finnhub.io/api/news?id=09c126c21048de0c45be1453c1e674996a9676c238ee20492c87f00f2bb31aaf","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Medtronic's Q4 results may get a lift from broad MedSurg growth, strong Cardiovascular demand and continued momentum in Diabetes.","category":"company","datetime":1779810180,"headline":"Broad-Based MedSurg Growth Likely to Aid MDT's Q4 Performance"}, {"id":140414651,"url":"https://finnhub.io/api/news?id=5100e95a94c08c3b920ca86044bf863661833a73ea39730e8d351fd986c3bca4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp Holdings has lagged behind the broader market over the past year, yet analysts remain highly optimistic about the stock’s prospects.","category":"company","datetime":1779722462,"headline":"What Are Wall Street Analysts' Target Price for Labcorp Holdings Stock?"}, {"id":140404664,"url":"https://finnhub.io/api/news?id=77ed0ea7e926c76a7a0ebe0acddd9b686b25c54efaf669d91cd79f158b532059","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...","category":"company","datetime":1779624160,"headline":"Should Income Investors Look At Labcorp Holdings Inc. (NYSE:LH) Before Its Ex-Dividend?"}

data_source finnhub_news_keyword_model

article_count 6

negative_hits 0

positive_hits 0

recomputed_at_score true

sentiment_score_raw 0

source_article_count 21

discarded_article_count 15

sentimentPoints 2

Dimension contribution

Dimension Raw Max Norm % Contrib

基本面 3.6 5/110 72% 3.6

資金流 15.6 20/110 78% 15.6

市場環境 9 15/110 60% 9

催化劑 2 20/110 10% 2

風險管理 7.4 10/110 74% 7.4

技術信號 19.4 30/110 64.67% 19.4

情緒分析 2 10/110 20% 2

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 23/50

ret_5d 0.0835

max_score 50

max_total 50

raw_total 23

vcp_bonus 0

vol_ratio 1.5836

ret_points 12

vol_points 6

range_ratio 1.5765

volat_points 4

day_range_pct 0.0317

model_version cursor_18_27_news_v2_160

available_bars 30

breakout_points 0

partial_history false

pullback_points 1

breakout_vol_bonus 0

first_breakout_20d false

return_window_days 5

first_breakout_bonus 0

breakout_quality_points 0

Risk management

level Medium

reason risk management score >= 6.5/10

position

score 1.6

details

atrPct 2.3357

turnoverUsdM 325.2736

liquidityPoints 0.6

volatilityPoints 1

rrPoints 1.4

stopLevels

symbol US.LH

rr_range 1:1.0-1:2.5

risk_profile 中等

stop_loss_price 258.6358

strength_details

ma_score 1

atr_score 2

rsi_score 0.5

macd_score 3

volume_score 2

market_adjustment 1

risk_reward_ratio 1.1

stop_loss_percent 4.7

take_profit_price 285.3572

target_multiplier 1.9

technical_strength 1.75

take_profit_percent 5.2

positionPoints 1.6

stopLossPoints 2.4

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used

sector Health Care

concentratedSectorPenalty 0

riskRewardRatio 1.2

stopLossPercent 4.6715

diversificationPoints 2

Calculation audit log

基本面分析總分: 3.6/5分
資金流分析總分: 15.6/20分
市場環境分析總分: 9/15分
催化劑分析: 2/20分
風險管理總分: 7.4/10分
技術信號分析總分: 19.4/30分
情緒分析: 2/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx

value 92.86

atr

atr 6.3371

rule ATR / current price; lower volatility scores higher

score 6

atr_pct 2.34

cci

rule Cursor_18.24 CCI bands

level 超買或超賣風險

score 2

value 224.05

cmf

rule Cursor_18.24 CMF bands

level 資金流入

score 8

value 0.2977

kdj

d 73.42

j 103.99

k 83.61

rule Cursor_18.24 K/D cross

score 4

signal 金叉

mfi

rule Cursor_18.24 MFI bands

level 入貨中

score 8

value 61.34

obv

rule Cursor_18.24 recent_slope vs previous_slope

score 10

trend 強流入

value 2225300

recentSlope 482990

previousSlope 151060

rsi

value 70.55

sar

rule Cursor_18.24 Parabolic SAR

score 8

trend 上升

value 252.8895

position SAR喺價下

distancePct 6.79

previousTrend 上升

ma50

value 259.9272

macd

macd 1.8296

trend 強烈看漲

signal -0.6406

histogram 2.4702

vwap

rule Cursor_18.24 VWAP 20D consecutive close

score 8

value 256.9484

position 連續3日>VWAP

consecutiveAbove 4

volume

rule Cursor_18.24 volume ratio

level 有量

ratio 1.57

score 6

avgVolume 763870

currentVolume 1198900

derived

ma20 256.42

ma50 259.9272

prevClose 270.87

avgVolume10 946250

avgVolume20 763870

changePercent 0.16

avgVolumeForScore 763870

ma_cross

ma20 256.42

ma50 259.9272

rule Cursor_18.24 MA20/MA50 cross

cross 熊勢

score 0

prevMa20 255.456

prevMa50 259.5148

spreadPct 1.35

isVolumeBreakout false

bollinger

lower 243.4903

upper 269.3497

position 上半部

rsi_short

value 93.64

macd_short

macd 0

trend 中性

signal 0

histogram 0

volume_ratio

ratio 1.57

Raw calculation JSON

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.3357414028233388,
        "turnoverUsdM": 325.273559,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.LH",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 258.6358,
      "strength_details": {
        "ma_score": 1,
        "atr_score": 2,
        "rsi_score": 0.5,
        "macd_score": 3,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.1,
      "stop_loss_percent": 4.7,
      "take_profit_price": 285.3572,
      "target_multiplier": 1.9,
      "technical_strength": 1.75,
      "take_profit_percent": 5.2
    },
    "positionPoints": 1.6,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 4.6714828056466775,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 82,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 59,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 23
  },
  "market": {
    "ma20": 256.42,
    "ma50": 259.9272,
    "close": 271.31,
    "prevClose": 270.87,
    "avgVolume20": 763870,
    "volumeRatio": 1.57,
    "changePercent": 0.16
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred+database-backfill-market-proxy"
  },
  "barCount": 145,
  "momentum": {
    "max": 50,
    "result": 23,
    "details": {
      "ret_5d": 0.0835496625264589,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 23,
      "vcp_bonus": 0,
      "vol_ratio": 1.5836261326711225,
      "ret_points": 12,
      "vol_points": 6,
      "range_ratio": 1.576460149758592,
      "volat_points": 4,
      "day_range_pct": 0.03169809443072499,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 82,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.6,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 72,
        "contribution": 3.6
      },
      {
        "raw": 15.6,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 78,
        "contribution": 15.6
      },
      {
        "raw": 9,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 60,
        "contribution": 9
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.4,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 74,
        "contribution": 7.4
      },
      {
        "raw": 19.4,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 64.67,
        "contribution": 19.4
      },
      {
        "raw": 2,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 20,
        "contribution": 2
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 59,
    "details": [
      "基本面分析總分: 3.6/5分",
      "資金流分析總分: 15.6/20分",
      "市場環境分析總分: 9/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.4/10分",
      "技術信號分析總分: 19.4/30分",
      "情緒分析: 2/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.6,
      "資金流": 15.6,
      "市場環境": 9,
      "情緒分析": 2,
      "技術信號": 19.4,
      "風險管理": 7.4
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 6,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "良好",
        "items": {
          "pbPoints": 0.5,
          "pePoints": 0.4,
          "epsPoints": 0.6,
          "roePoints": 0.4,
          "debtPoints": 0.4,
          "marginPoints": 0,
          "turnoverUsdM": 325.273559,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "良好",
        "items": {
          "cmfPoints": 3.2,
          "mfiPoints": 3.2,
          "obvPoints": 4,
          "vwapPoints": 3.2,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.LH",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 1.8,
            "details": {
              "source": "twelvedata+fred+database-backfill-market-proxy",
              "vixClose": 20.09
            }
          },
          "trend": {
            "score": 3.4,
            "details": {
              "qqq": {
                "ma20": 121.98465392607886,
                "ma50": 119.41417806680984,
                "name": "QQQ",
                "close": 120.02993738567542,
                "points": 1.4
              },
              "spy": {
                "ma20": 112.53347409917129,
                "ma50": 110.23726906087428,
                "name": "SPY",
                "close": 112.77327192153848,
                "points": 2
              },
              "source": "twelvedata+fred+database-backfill-market-proxy"
            }
          },
          "atrPct": 2.3357414028233388,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 1.8,
          "marketTrendPoints": 3.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 6,
              "negativeHits": 0,
              "positiveHits": 0,
              "sentimentScoreRaw": 0
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 140639073,
                "url": "https://finnhub.io/api/news?id=de61a69e5ebc70655f7e5d02d4a50ab3177fa3118cf0d4825d9bba0012b8097f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "LH vs. CRL: Which Stock Is the Better Value Option?",
                "category": "company",
                "datetime": 1781538002,
                "headline": "LH vs. CRL: Which Stock Is the Better Value Option?"
              },
              {
                "id": 140515389,
                "url": "https://finnhub.io/api/news?id=774538fd07490db4d638cadcc28a6d53b616073e8763adf671ba041005d7aa10",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "LH",
                "summary": "Labcorp Holdings Inc. (LH) Jefferies Global Healthcare Conference 2026 June 3, 2026 12:15 PM EDTCompany ParticipantsJulia Wang - CFO & Executive...",
                "category": "company",
                "datetime": 1780496542,
                "headline": "Labcorp Holdings Inc. (LH) Presents at Jefferies Global Healthcare Conference 2026 Transcript"
              },
              {
                "id": 140498514,
                "url": "https://finnhub.io/api/news?id=5e114c37ae4f826480cb1dd39e86fd2dc55d4daf9554d5b12c9e62ed4bf7f48a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings stock snapshot Labcorp Holdings (LH) stock has been moving without a clear single catalyst, which leads many investors to focus on its fundamentals, including recent returns, revenue, earnings and its current valuation profile. See our latest analysis for Labcorp Holdings. At a share price of $256.87, Labcorp Holdings has seen its short term share price momentum cool, with the share price down over the past week and three months, while longer term total shareholder returns...",
                "category": "company",
                "datetime": 1780395006,
                "headline": "Assessing Labcorp (LH) Valuation As Shares Cool And P/E Trails Healthcare Peers"
              },
              {
                "id": 140488110,
                "url": "https://finnhub.io/api/news?id=992ea0469bef42f8b40689dfd5fdd6a55766857139763ab422f12ec43ea79f96",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp joins a national CRC trial as exclusive genetic testing provider, expanding Invitae-based testing and supporting cancer research.",
                "category": "company",
                "datetime": 1780319460,
                "headline": "LH Expands Genetic Testing in CRC Through New Collab: Stock to Gain?"
              },
              {
                "id": 140434993,
                "url": "https://finnhub.io/api/news?id=d1e6611cf84320753cff656dc5eef71bf4c5d2bd577c2049db524448cdb630bd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "LH vs. MEDP: Which Stock Is the Better Value Option?",
                "category": "company",
                "datetime": 1779896402,
                "headline": "LH or MEDP: Which Is the Better Value Stock Right Now?"
              },
              {
                "id": 140404664,
                "url": "https://finnhub.io/api/news?id=77ed0ea7e926c76a7a0ebe0acddd9b686b25c54efaf669d91cd79f158b532059",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...",
                "category": "company",
                "datetime": 1779624160,
                "headline": "Should Income Investors Look At Labcorp Holdings Inc. (NYSE:LH) Before Its Ex-Dividend?"
              }
            ],
            "raw_source": [
              {
                "id": 140665236,
                "url": "https://finnhub.io/api/news?id=10a66dda14b20e65fc5be2ae6f7932dd68373d8b45a9c33eed65c7ea20cc6dbe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.",
                "category": "company",
                "datetime": 1781789504,
                "headline": "Is Labcorp Holdings Stock Underperforming the Nasdaq?"
              },
              {
                "id": 140639073,
                "url": "https://finnhub.io/api/news?id=de61a69e5ebc70655f7e5d02d4a50ab3177fa3118cf0d4825d9bba0012b8097f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "LH vs. CRL: Which Stock Is the Better Value Option?",
                "category": "company",
                "datetime": 1781538002,
                "headline": "LH vs. CRL: Which Stock Is the Better Value Option?"
              },
              {
                "id": 140618832,
                "url": "https://finnhub.io/api/news?id=272569004de73cf01b174436efcaf73184901a79faac62435280a914530782e9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
                "category": "company",
                "datetime": 1781270103,
                "headline": "CVS Health Corporation (CVS) Hit a 52 Week High, Can the Run Continue?"
              },
              {
                "id": 140609077,
                "url": "https://finnhub.io/api/news?id=52cb62043ec768f9f9e24fc0e0a86cb23b7137eb792de52b160b3f0acbca4f07",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Danaher is seeing strong Biotechnology growth as bioprocessing demand rises, with equipment orders up more than 30% and core revenue gains expected in 2026.",
                "category": "company",
                "datetime": 1781190900,
                "headline": "Strong Performance Continues at DHR's Biotechnology Unit: What's Next?"
              },
              {
                "id": 140592983,
                "url": "https://finnhub.io/api/news?id=4b4d210212f29130131f5753f26b586179aa36b63499bc98b011610995370363",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.",
                "category": "company",
                "datetime": 1781099608,
                "headline": "2 S&P 500 Stocks for Long-Term Investors and 1 Facing Challenges"
              },
              {
                "id": 140571189,
                "url": "https://finnhub.io/api/news?id=9ada86ca899821337305d9c82d593c39853287fee467adf28995985167622996",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp OnDemand enables convenient testing with the NASHnext® test, within a physician-directed care pathway to support identification of patients with at-risk MASH This model expands access and supports adoption of NASHnext®, enabling testing across a wider patient population Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), June 8, 2026 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threateni",
                "category": "company",
                "datetime": 1780934400,
                "headline": "GENFIT: NASHnext®, Powered by GENFIT's Non-invasive Diagnostic Technology NIS4®, Launched via Labcorp’s OnDemand Offering for Identification of At-Risk MASH"
              },
              {
                "id": 140535106,
                "url": "https://finnhub.io/api/news?id=c57369c47aa907aaf1780d15a262ad0b4f4f1dab02017c63aa94889e370381aa",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "LH",
                "summary": "Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.",
                "category": "company",
                "datetime": 1780662900,
                "headline": "Top S&P500 movers in Friday's pre-market session"
              },
              {
                "id": 140525739,
                "url": "https://finnhub.io/api/news?id=c5513d86ae4d6e92580370a84278b71d8dbd2b6fa350581d6e3c27b2b5bec21a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1780587021,
                "headline": "Why Is Pediatrix Medical Group (MD) Down 1.7% Since Last Earnings Report?"
              },
              {
                "id": 140515389,
                "url": "https://finnhub.io/api/news?id=774538fd07490db4d638cadcc28a6d53b616073e8763adf671ba041005d7aa10",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "LH",
                "summary": "Labcorp Holdings Inc. (LH) Jefferies Global Healthcare Conference 2026 June 3, 2026 12:15 PM EDTCompany ParticipantsJulia Wang - CFO & Executive...",
                "category": "company",
                "datetime": 1780496542,
                "headline": "Labcorp Holdings Inc. (LH) Presents at Jefferies Global Healthcare Conference 2026 Transcript"
              },
              {
                "id": 140498514,
                "url": "https://finnhub.io/api/news?id=5e114c37ae4f826480cb1dd39e86fd2dc55d4daf9554d5b12c9e62ed4bf7f48a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings stock snapshot Labcorp Holdings (LH) stock has been moving without a clear single catalyst, which leads many investors to focus on its fundamentals, including recent returns, revenue, earnings and its current valuation profile. See our latest analysis for Labcorp Holdings. At a share price of $256.87, Labcorp Holdings has seen its short term share price momentum cool, with the share price down over the past week and three months, while longer term total shareholder returns...",
                "category": "company",
                "datetime": 1780395006,
                "headline": "Assessing Labcorp (LH) Valuation As Shares Cool And P/E Trails Healthcare Peers"
              },
              {
                "id": 140488110,
                "url": "https://finnhub.io/api/news?id=992ea0469bef42f8b40689dfd5fdd6a55766857139763ab422f12ec43ea79f96",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp joins a national CRC trial as exclusive genetic testing provider, expanding Invitae-based testing and supporting cancer research.",
                "category": "company",
                "datetime": 1780319460,
                "headline": "LH Expands Genetic Testing in CRC Through New Collab: Stock to Gain?"
              },
              {
                "id": 140458416,
                "url": "https://finnhub.io/api/news?id=ea3715563c18fce156cc272ed85db7157100b2cf49b370dc126207b518094d10",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.",
                "category": "company",
                "datetime": 1780067558,
                "headline": "3 Cash-Producing Stocks That Concern Us"
              },
              {
                "id": 140456467,
                "url": "https://finnhub.io/api/news?id=31fb7e3919ea2811fb4a43a76978f99bd6ff3db924deb8372d17967db068cc1c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced a collaboration with the Alliance for Clinical Trials in Oncology to advance a national, multicenter clinical trial for patients newly diagnosed with colorectal cancer (CRC). The trial will evaluate approaches to increase germline genetic testing among at-risk family members, as well as the impact of multigene panel testing on care for newly diagnosed patients. Leveraging its Invitae testing,",
                "category": "company",
                "datetime": 1780052400,
                "headline": "Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer"
              },
              {
                "id": 140464997,
                "url": "https://finnhub.io/api/news?id=1eb1dd8b7ae4ff7cd771703e1a7b4e1fd1583afcf7e686d0adce9046489559b7",
                "image": "",
                "source": "Benzinga",
                "related": "LH",
                "summary": "The trial will evaluate approaches to increase germline genetic testing among at-risk family members, as well as the impact of multigene panel testing on care for newly diagnosed patients. Leveraging its Invitae testing,",
                "category": "company",
                "datetime": 1780038340,
                "headline": "Labcorp Enters Collaboration The Alliance For Clinical Trials In Oncology To Advance A National, Multicenter Clinical Trial For Patients Newly Diagnosed With Colorectal Cancer"
              },
              {
                "id": 140442845,
                "url": "https://finnhub.io/api/news?id=6102a259c1b9ea27cb85e6e3a53b61e2778334934272b0572fad7ec970c3755e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the availability of its expanded DPYD Genotyping test to help identify cancer patients who may be at increased risk for severe or life-threatening side effects from fluoropyrimidine chemotherapy. Labcorp now offers genotype testing for all DPYD Tier 1 and Tier 2 variants recommended by the Association for Molecular Pathology (AMP).",
                "category": "company",
                "datetime": 1779966000,
                "headline": "Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side Effects"
              },
              {
                "id": 140451399,
                "url": "https://finnhub.io/api/news?id=49eec411d6f77958e2edbce8a614fc36185036e211809ab8a22185b60771a44f",
                "image": "",
                "source": "Benzinga",
                "related": "LH",
                "summary": "New pharmacogenomic test detects all DPYD variants recommended by the Association for Molecular Pathology to support safer, more personalized cancer treatmentBURLINGTON, N.C., May 28, 2026 /PRNewswire/ -- Labcorp",
                "category": "company",
                "datetime": 1779952443,
                "headline": "Labcorp Announces Availability Of Expanded DPYD Genotyping Test To Help Identify Cancer Patients At Increased Risk For Severe Fluoropyrimidine Chemotherapy Side Effects"
              },
              {
                "id": 140434993,
                "url": "https://finnhub.io/api/news?id=d1e6611cf84320753cff656dc5eef71bf4c5d2bd577c2049db524448cdb630bd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "LH vs. MEDP: Which Stock Is the Better Value Option?",
                "category": "company",
                "datetime": 1779896402,
                "headline": "LH or MEDP: Which Is the Better Value Stock Right Now?"
              },
              {
                "id": 140432140,
                "url": "https://finnhub.io/api/news?id=b031e67f0c819876a02e9d062a5b32091e021a3b10907f4ff168655635a23816",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that the company will present at the 2026 Jefferies Global Healthcare Conference in New York on Wednesday, June 3, from 12:15 pm to 12:45 pm ET.",
                "category": "company",
                "datetime": 1779883200,
                "headline": "Labcorp to Present at the Jefferies Global Healthcare Conference"
              },
              {
                "id": 140422829,
                "url": "https://finnhub.io/api/news?id=09c126c21048de0c45be1453c1e674996a9676c238ee20492c87f00f2bb31aaf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Medtronic's Q4 results may get a lift from broad MedSurg growth, strong Cardiovascular demand and continued momentum in Diabetes.",
                "category": "company",
                "datetime": 1779810180,
                "headline": "Broad-Based MedSurg Growth Likely to Aid MDT's Q4 Performance"
              },
              {
                "id": 140414651,
                "url": "https://finnhub.io/api/news?id=5100e95a94c08c3b920ca86044bf863661833a73ea39730e8d351fd986c3bca4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings has lagged behind the broader market over the past year, yet analysts remain highly optimistic about the stock’s prospects.",
                "category": "company",
                "datetime": 1779722462,
                "headline": "What Are Wall Street Analysts' Target Price for Labcorp Holdings Stock?"
              },
              {
                "id": 140404664,
                "url": "https://finnhub.io/api/news?id=77ed0ea7e926c76a7a0ebe0acddd9b686b25c54efaf669d91cd79f158b532059",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...",
                "category": "company",
                "datetime": 1779624160,
                "headline": "Should Income Investors Look At Labcorp Holdings Inc. (NYSE:LH) Before Its Ex-Dividend?"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 6,
            "negative_hits": 0,
            "positive_hits": 0,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0,
            "source_article_count": 21,
            "discarded_article_count": 15
          },
          "sentimentPoints": 2
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 19.4,
        "grade": "一般",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 0.9,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.9,
            "vcp_reason": "站上MA50；升放量(近10日4日)；Ready=N；Confirm=Y",
            "vcp_metrics": {
              "up_days": 6,
              "vol_ref": 694990,
              "down_days": 3,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 882510,
              "avg_vol_20": 757060,
              "avg_vol_30": 694990,
              "range_pct_10": 0.09807965058420251,
              "range_pct_20": 0.09807965058420251,
              "range_pct_30": 0.09807965058420251,
              "up_expand_ok": true,
              "lookback_used": 79,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 4,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.269816831896862,
              "dist_to_20d_high": 0.001104488093387065,
              "down_shrink_days": 2,
              "breakout_level_20d": 271.60999,
              "vcp_breakout_confirm": true,
              "contraction_ratio_10_30": 1
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 0,
          "shortRsiPoints": 0.4,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 1,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.3357414028233388,
              "turnoverUsdM": 325.273559,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.LH",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 258.6358,
            "strength_details": {
              "ma_score": 1,
              "atr_score": 2,
              "rsi_score": 0.5,
              "macd_score": 3,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.1,
            "stop_loss_percent": 4.7,
            "take_profit_price": 285.3572,
            "target_multiplier": 1.9,
            "technical_strength": 1.75,
            "take_profit_percent": 5.2
          },
          "positionPoints": 1.6,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 4.6714828056466775,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 92.86,
    "atr": {
      "atr": 6.3371,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.34
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 224.05
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "資金流入",
      "score": 8,
      "value": 0.2977
    },
    "kdj": {
      "d": 73.42,
      "j": 103.99,
      "k": 83.61,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "入貨中",
      "score": 8,
      "value": 61.34
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 2225300,
      "recentSlope": 482990,
      "previousSlope": 151060
    },
    "rsi": 70.55,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 252.8895,
      "position": "SAR喺價下",
      "distancePct": 6.79,
      "previousTrend": "上升"
    },
    "ma50": 259.9272,
    "macd": {
      "macd": 1.829623018994596,
      "trend": "強烈看漲",
      "signal": -0.6405672780015015,
      "histogram": 2.4701902969960976
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 8,
      "value": 256.9484,
      "position": "連續3日>VWAP",
      "consecutiveAbove": 4
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.57,
      "score": 6,
      "avgVolume": 763870,
      "currentVolume": 1198900
    },
    "derived": {
      "ma20": 256.42,
      "ma50": 259.9272,
      "prevClose": 270.87,
      "avgVolume10": 946250,
      "avgVolume20": 763870,
      "changePercent": 0.16,
      "avgVolumeForScore": 763870
    },
    "ma_cross": {
      "ma20": 256.42,
      "ma50": 259.9272,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "熊勢",
      "score": 0,
      "prevMa20": 255.456,
      "prevMa50": 259.5148,
      "spreadPct": 1.35,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 243.4903,
      "upper": 269.3497,
      "position": "上半部"
    },
    "rsi_short": 93.64,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.57
    }
  }
}

Raw metrics JSON

{
  "close": 271.31,
  "volume": 1198900,
  "changePercent": 0.16
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.

US.LH · Labcorp

觀望

Score and price trend

Summary

Rolling setup rating

Has the score quality changed?

Signals

Full calculation detail

Market inputs

Metrics snapshot

110-point main rating

基本面 — 3.6/5 · 良好

Sub-items

資金流 — 15.6/20 · 良好

Sub-items

institutional

details

warning

市場環境 — 9/15 · 一般

Sub-items

vix

details

trend

details

qqq

spy

催化劑 — 2/20 · 較差

Sub-items

catalyst

details

風險管理 — 7.4/10 · 良好

Sub-items

position

details

stopLevels

strength_details

diversification

details

技術信號 — 19.4/30 · 一般

Sub-items

vcpPayload

vcp_metrics

情緒分析 — 2/10 · 較差

Sub-items

sentiment

details

sentimentData

Dimension contribution

5D momentum v2 breakdown

Risk management

position

details

stopLevels

strength_details

diversification

details

Calculation audit log

Technical indicators

Raw calculation JSON

Raw metrics JSON